DSC Advisors L.P. Has $7.07 Million Stock Holdings in R1 RCM Inc. (NASDAQ:RCM)

DSC Advisors L.P. cut its holdings in R1 RCM Inc. (NASDAQ:RCM - Free Report) by 46.1% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 562,687 shares of the healthcare provider's stock after selling 480,313 shares during the period. R1 RCM comprises 23.6% of DSC Advisors L.P.'s holdings, making the stock its largest holding. DSC Advisors L.P. owned approximately 0.13% of R1 RCM worth $7,067,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Advisors Asset Management Inc. bought a new stake in shares of R1 RCM in the 1st quarter worth about $27,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of R1 RCM during the 2nd quarter worth about $86,000. QRG Capital Management Inc. purchased a new position in shares of R1 RCM during the 1st quarter worth about $132,000. CIBC Asset Management Inc purchased a new position in shares of R1 RCM during the 2nd quarter worth about $149,000. Finally, Covestor Ltd boosted its stake in shares of R1 RCM by 340.9% during the 1st quarter. Covestor Ltd now owns 13,438 shares of the healthcare provider's stock worth $172,000 after purchasing an additional 10,390 shares during the period. 61.10% of the stock is currently owned by institutional investors.

R1 RCM Stock Up 0.1 %

Shares of NASDAQ:RCM traded up $0.02 during trading hours on Thursday, hitting $14.17. The company's stock had a trading volume of 1,528,387 shares, compared to its average volume of 3,742,999. R1 RCM Inc. has a 52 week low of $8.87 and a 52 week high of $15.43. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.84 and a quick ratio of 1.84. The company has a market capitalization of $5.98 billion, a price-to-earnings ratio of -177.13 and a beta of 0.84. The firm's fifty day moving average price is $13.89 and its 200 day moving average price is $13.02.

R1 RCM (NASDAQ:RCM - Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.03. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The business had revenue of $627.90 million during the quarter, compared to analyst estimates of $633.10 million. The company's quarterly revenue was up 12.0% on a year-over-year basis. As a group, research analysts expect that R1 RCM Inc. will post -0.24 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on RCM shares. TD Cowen reaffirmed a "hold" rating and set a $14.30 price target (down from $20.00) on shares of R1 RCM in a research note on Monday, August 5th. Stephens cut shares of R1 RCM from an "overweight" rating to an "equal weight" rating in a research note on Thursday, August 1st. Canaccord Genuity Group reaffirmed a "buy" rating and set a $15.00 price target on shares of R1 RCM in a research note on Monday, July 22nd. Robert W. Baird reaffirmed an "outperform" rating and set a $18.00 price target on shares of R1 RCM in a research note on Tuesday, July 2nd. Finally, Jefferies Financial Group cut shares of R1 RCM from a "buy" rating to a "hold" rating in a research report on Thursday, August 1st. Thirteen analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $15.41.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.